Introduction: The current use of arterial punctures, when obtaining arterial blood gas and acid-base status of patients, are associated with a risk of side effects such as pain and hematoma, and a small risk of more severe complications. This analysis investigated the cost-effectiveness of a new method, where less painful venous-converted tests are used as an alternative to arterial punctures.
Methods: A cost-utility analysis was conducted from the Danish hospital perspective using a Markov model. The model represents the admission of a typical patient suffering from chronic obstructive pulmonary disease to the Department of Pulmonary Medicine, Aalborg Hospital. Evidence of the effect of the venous-converted tests' pain reduction was converted into short-term gain in quality-adjusted life years (QALYs), using the Danish EuroQol-5 Dimension value set. A Monte Carlo second order simulation of 10,000 hypothetical patients was conducted for a midsized and a small department.
Results: Monte Carlo simulation of the incremental cost-effectiveness ratio (ICER) was dominant for a midsized department, and for a small department the mean was £10,645 per QALY gained. The scatter plot of ICERs revealed that at a willingness-to-pay (WTP) of £30,000 per QALY gained, the venous conversion method is >95% cost-effective in a midsized department and 51% in a small department.
Conclusion: It was concluded that the venous conversion method should be applied to hospitals with midsized pulmonary departments, and could be applied to small pulmonary departments if the WTP is sufficient.
Keywords: Markov model; arterial punctures; cost–utility analysis; hematoma; pain.